These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35278410)

  • 21. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
    Laurila PP; Naukkarinen J; Kristiansson K; Ripatti S; Kauttu T; Silander K; Salomaa V; Perola M; Karhunen PJ; Barter PJ; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):346-52. PubMed ID: 19910639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
    Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
    Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).
    Raj R; Bhatti JS; Badada SK; Ramteke PW
    Diabetes Metab Res Rev; 2015 Oct; 31(7):663-71. PubMed ID: 25470794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
    Merkel M; Loeffler B; Kluger M; Fabig N; Geppert G; Pennacchio LA; Laatsch A; Heeren J
    J Biol Chem; 2005 Jun; 280(22):21553-60. PubMed ID: 15774484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of genetically-influenced phospholipid transfer protein activity in lipoprotein metabolism and coronary artery disease.
    Ao L; Noordam R; Rensen PCN; van Heemst D; Willems van Dijk K
    J Clin Lipidol; 2024; 18(4):e579-e587. PubMed ID: 38906750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
    Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.
    Yang Y; Beigneux AP; Song W; Nguyen LP; Jung H; Tu Y; Weston TA; Tran CM; Xie K; Yu RG; Tran AP; Miyashita K; Nakajima K; Murakami M; Chen YQ; Zhen EY; Kim JR; Kim PH; Birrane G; Tontonoz P; Ploug M; Konrad RJ; Fong LG; Young SG
    J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates.
    Gesteiro E; Bastida S; Vázquez-Velasco M; Corella D; Guillén M; Ordovas JM; Sánchez-Muniz FJ
    Eur J Pediatr; 2011 Dec; 170(12):1551-8. PubMed ID: 21505768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese.
    Bi N; Yan SK; Li GP; Yin ZN; Chen BS
    Mol Genet Metab; 2004 Nov; 83(3):280-6. PubMed ID: 15542401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals.
    Takeuchi F; Isono M; Katsuya T; Yokota M; Yamamoto K; Nabika T; Shimokawa K; Nakashima E; Sugiyama T; Rakugi H; Yamaguchi S; Ogihara T; Yamori Y; Kato N
    PLoS One; 2012; 7(9):e46385. PubMed ID: 23050023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
    Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
    PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.
    OʼBrien SE; Schrodi SJ; Ye Z; Brilliant MH; Virani SS; Brautbar A
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):183-8. PubMed ID: 25900265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries.
    Yang Y; Konrad RJ; Ploug M; Young SG
    J Lipid Res; 2024 Jul; 65(7):100578. PubMed ID: 38880127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.
    Hopkins PN; Nanjee MN; Wu LL; McGinty MG; Brinton EA; Hunt SC; Anderson JL
    Atherosclerosis; 2009 Dec; 207(2):559-66. PubMed ID: 19524242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
    J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.